225 related articles for article (PubMed ID: 24732673)
1. Insulin-sensitizing effect of LXR agonist T0901317 in high-fat fed rats is associated with restored muscle GLUT4 expression and insulin-stimulated AS160 phosphorylation.
Baranowski M; Zabielski P; Błachnio-Zabielska AU; Harasim E; Chabowski A; Górski J
Cell Physiol Biochem; 2014; 33(4):1047-57. PubMed ID: 24732673
[TBL] [Abstract][Full Text] [Related]
2. Liver X receptor agonist T0901317 enhanced peroxisome proliferator-activated receptor-delta expression and fatty acid oxidation in rat skeletal muscle.
Baranowski M; Blachnio-Zabielska AU; Zabielski P; Harasim E; Harasiuk D; Chabowski A; Gorski J
J Physiol Pharmacol; 2013 Jun; 64(3):289-97. PubMed ID: 23959725
[TBL] [Abstract][Full Text] [Related]
3. LXR agonist T0901317-Induced hyperlipidemia does not lead to lipid accumulation in the rat heart.
Harasiuk D; Baranowski M; Zabielski P; Chabowski A; Górski J
Cell Physiol Biochem; 2015; 35(3):1095-106. PubMed ID: 25659329
[TBL] [Abstract][Full Text] [Related]
4. Fetal liver X receptor activation acutely induces lipogenesis but does not affect plasma lipid response to a high-fat diet in adult mice.
van Straten EM; van Meer H; Huijkman NC; van Dijk TH; Baller JF; Verkade HJ; Kuipers F; Plösch T
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1171-8. PubMed ID: 19724022
[TBL] [Abstract][Full Text] [Related]
5. Cilostazol inhibits insulin-stimulated expression of sterol regulatory binding protein-1c via inhibition of LXR and Sp1.
Jung YA; Kim HK; Bae KH; Seo HY; Kim HS; Jang BK; Jung GS; Lee IK; Kim MK; Park KG
Exp Mol Med; 2014 Jan; 46(1):e73. PubMed ID: 24458133
[TBL] [Abstract][Full Text] [Related]
6. Regulation of insulin resistance and adiponectin signaling in adipose tissue by liver X receptor activation highlights a cross-talk with PPARγ.
Zheng F; Zhang S; Lu W; Wu F; Yin X; Yu D; Pan Q; Li H
PLoS One; 2014; 9(6):e101269. PubMed ID: 24972069
[TBL] [Abstract][Full Text] [Related]
7. Activation of the Liver X Receptor by Agonist TO901317 Improves Hepatic Insulin Resistance via Suppressing Reactive Oxygen Species and JNK Pathway.
Dong Y; Gao G; Fan H; Li S; Li X; Liu W
PLoS One; 2015; 10(4):e0124778. PubMed ID: 25909991
[TBL] [Abstract][Full Text] [Related]
8. Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines.
Meng ZX; Yin Y; Lv JH; Sha M; Lin Y; Gao L; Zhu YX; Sun YJ; Han X
Diabetologia; 2012 Jun; 55(6):1733-44. PubMed ID: 22415588
[TBL] [Abstract][Full Text] [Related]
9. Ursodeoxycholic acid inhibits liver X receptor α-mediated hepatic lipogenesis via induction of the nuclear corepressor SMILE.
Lee JM; Gang GT; Kim DK; Kim YD; Koo SH; Lee CH; Choi HS
J Biol Chem; 2014 Jan; 289(2):1079-91. PubMed ID: 24265317
[TBL] [Abstract][Full Text] [Related]
10. Liver X receptor regulates rheumatoid arthritis fibroblast-like synoviocyte invasiveness, matrix metalloproteinase 2 activation, interleukin-6 and CXCL10.
Laragione T; Gulko PS
Mol Med; 2012 Sep; 18(1):1009-17. PubMed ID: 22634718
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of a PPAR-delta agonist to rodents worsens, not improves, maximal insulin-stimulated glucose transport in skeletal muscle of different fibers.
Cresser J; Bonen A; Chabowski A; Stefanyk LE; Gulli R; Ritchie I; Dyck DJ
Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R470-9. PubMed ID: 20538899
[TBL] [Abstract][Full Text] [Related]
12. Liver X Receptor Agonist TO901317 Prevents Diacylglycerols Accumulation in the Heart of Streptozotocin-Diabetic Rats.
Harasiuk D; Baranowski M; Zabielski P; Chabowski A; Górski J
Cell Physiol Biochem; 2016; 39(1):350-9. PubMed ID: 27352290
[TBL] [Abstract][Full Text] [Related]
13. PPARα-LXR as a novel metabolostatic signalling axis in skeletal muscle that acts to optimize substrate selection in response to nutrient status.
Caton PW; Holness MJ; Bishop-Bailey D; Sugden MC
Biochem J; 2011 Aug; 437(3):521-30. PubMed ID: 21609322
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of AMPK suppression of LXR-dependent Srebp-1c transcription.
Yap F; Craddock L; Yang J
Int J Biol Sci; 2011; 7(5):645-50. PubMed ID: 21647332
[TBL] [Abstract][Full Text] [Related]
15. Whole body glucoregulation and tissue-specific glucose uptake in a novel Akt substrate of 160 kDa knockout rat model.
Arias EB; Zheng X; Agrawal S; Cartee GD
PLoS One; 2019; 14(4):e0216236. PubMed ID: 31034517
[TBL] [Abstract][Full Text] [Related]
16. n-3 fatty acids ameliorate hepatic steatosis and dysfunction after LXR agonist ingestion in mice.
Jung UJ; Millman PN; Tall AR; Deckelbaum RJ
Biochim Biophys Acta; 2011 Sep; 1811(9):491-7. PubMed ID: 21704188
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice.
Chen Y; Duan Y; Yang X; Sun L; Liu M; Wang Q; Ma X; Zhang W; Li X; Hu W; Miao RQ; Xiang R; Hajjar DP; Han J
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):948-59. PubMed ID: 25810299
[TBL] [Abstract][Full Text] [Related]
18. Concurrent activation of liver X receptor and peroxisome proliferator-activated receptor alpha exacerbates hepatic steatosis in high fat diet-induced obese mice.
Gao M; Bu L; Ma Y; Liu D
PLoS One; 2013; 8(6):e65641. PubMed ID: 23762402
[TBL] [Abstract][Full Text] [Related]
19. Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits.
Honzumi S; Shima A; Hiroshima A; Koieyama T; Terasaka N
Biochim Biophys Acta; 2011 Dec; 1811(12):1136-45. PubMed ID: 21875689
[TBL] [Abstract][Full Text] [Related]
20. LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins.
Basciano H; Miller A; Baker C; Naples M; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G323-32. PubMed ID: 19497957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
